Drug Topics e-News:
Having trouble viewing this email? View in a browser.
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
Subscribe Now
to Drug Topics e-News
Drug Topics, Voice of the Pharmacist, Hospital Pharmacists' Report
Part of the Modern Medicine Network
e-News
January 06, 2011
Drug Topics
In This Issue
Continuing Education
Newest: An update on Clostridium difficile infection
For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here
Meetings
Survey
This month we would like to know...

Approximately how much of your workday is spent dealing with insurance matters?
* 1/4 or less

* up to 1/3

* up to 1/2

* up to 2/3

* 3/4 or more
Click Here to Vote
Digital Edition
Drug Topics Digital Edition
View Current Edition
Subscribe to the Digital Edition
Many new cancer drugs require updated safety labels

Many serious or potentially fatal adverse reactions associated with new, targeted anti-cancer agents are not reported in the original published research on the drug, and they are not known to oncologists until years later when drug labels are updated, including boxed warnings, according to research published online in the Journal of Clinical Oncology, HealthDay News reported. Read full article.

DT Blog
Speers

A discussion generated by Drug Topics’ readers, editorial staff, and advisory board
Kristin Thienemann, PharmD candidate
Brittany Ward, PharmD candidate Kathleen Welch, PharmD candidate Kenneth Willinger III, PharmD candidate

Plan B: The debate continues
Read full article.

New online magazine aims to educate pharmacists on diabetes

Diabetes Health magazine launched Diabetes Health Pharmacist, a 24-page, bimonthly, online publication aimed at a readership of 25,000 U.S. licensed pharmacists. The magazine debuted in November. Read full article.

Daily aspirin tied to decreased risk of cancer mortality

Daily aspirin over at least 5 years appears to greatly reduce mortality from gastrointestinal and non-gastrointestinal cancers, according to research published online in The Lancet, HealthDay News reported. Read full article.

Combining statins and fibrates increases rhabdomyolysis risk

Patients who are newly treated with statin-fibrate concurrent therapy are slightly more likely to be hospitalized with rhabdomyolysis than those who take just one of the medications, according to research published in the American Journal of Cardiology, HealthDay News reported. Read full article.

Meetings and events

February 6-8, 2011 NACDS Regional Chain Conference
Naples, FL
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-837-4300

February 13, 2011 19th Annual WILLIAM R. BACON MEMORIAL Breakfast
6:30 a.m. - 8:45 a.m.
Palm Springs, CA
Contact:
800-333-7535; 760-325-6611

March 9-10, 2011 NACDS RxIMPACT Day on Capitol Hill
Washington, DC
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
hecker@nacds.org

March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678

March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734

CEC

Contact Us
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here
 

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.